News|Articles|February 12, 2018

Enhancing the Solubility of Poorly Soluble Drugs

External Link - PT1217 Dow-Brockhagen F&C pr3f-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

PharmTech Weekly News Roundup – Week of December 1, 2025

ByPatrick Lavery

December 5th 2025

Drug Digest: Closing the Gap in Modern Process Control and Automation for Quality

Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA

ByFeliza Mirasol

December 5th 2025

Aging process, rejuvenation anti-aging skin procedures old and young concept | Image Credit: © leszekglasner - stock.adobe.com

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

ByPatrick Lavery

December 4th 2025

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

ByJayaprakash Nair

December 3rd 2025

Medical banner Pulmonary fibrosis on blue background | Image Credit: © mi_viri -stock.adobe.com

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

BySusan Haigney

December 2nd 2025

Enhancing the Solubility of Poorly Soluble Drugs

Newsletter

Related Content

PharmTech Weekly News Roundup – Week of December 1, 2025

Drug Digest: Closing the Gap in Modern Process Control and Automation for QC/QA

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First

BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation

Trending on Pharmaceutical Technology

Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment

FDA Deploys Agentic AI Capabilities for Agency Staff

Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops

Immortal Dragons Will Help Etheros Target Aging and Related Diseases

Live Cell High-Content Imaging Is Driving Drug Discovery